CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Displaying 501 - 525 of 1543
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C54991 Cocaine use duration

Duration in months for which the subject/participant took or has taken cocaine

Supplemental Prior and Concomitant Medications Stroke Stroke
C54992 Cocaine exposure age start value

Age in years at which the subject/participant began exposure to cocaine

Supplemental Prior and Concomitant Medications Stroke Stroke
C54993 Cocaine exposure age end value

Age in years at which the subject/participant's exposure to cocaine ended

Exploratory Prior and Concomitant Medications Stroke Stroke
C54995 Potency enhancing drug current former use duration

Duration in months for which the subject/participant took or has taken the specified potency-enhancing drug

Exploratory Prior and Concomitant Medications Stroke Stroke
C54987 Stimulant current former use duration

Duration in months for which the subject/participant took or has taken the selected former or current stimulant

Supplemental Prior and Concomitant Medications Stroke Stroke
C54988 Stimulant current former use age start value

Age in years at which the subject/participant began taking the selected former or current stimulant

Supplemental Prior and Concomitant Medications Stroke Stroke
C54996 Potency enhancing drug current former use age start value

Age in years at which the subject/participant began taking the specified former or current potency-enhancing drug

Exploratory Prior and Concomitant Medications Stroke Stroke
C54989 Stimulant former use age end value

Age in years at which the subject/participant stopped taking the selected former stimulant

Supplemental Prior and Concomitant Medications Stroke Stroke
C54997 Potency enhancing drug former use age end value

Age in years at which the subject/participant stopped taking the specified potency-enhancing drug

Exploratory Prior and Concomitant Medications Stroke Stroke
C54999 Medication immunosuppressant current former take other text

The free-text field related to 'Medication immunosuppressant current former type' specifying other text

Exploratory Prior and Concomitant Medications Stroke Stroke
C54986 Stimulant current former use other text

The free-text field related to 'Stimulant current former use type' specifying other text

Supplemental Prior and Concomitant Medications Stroke Stroke
C54998 Medication immunosuppressant current former type

Type of immunosuppressant medication formerly or currently taken by the subject/participant

Exploratory Prior and Concomitant Medications Stroke Stroke
C54985 Stimulant current former use type

Type of stimulant formerly or currently taken by the subject/participant

Supplemental Prior and Concomitant Medications Stroke Stroke
C54994 Potency enhancing drug current former use type

Type of potency-enhancing drug formerly or currently taken by the subject/participant

Exploratory Prior and Concomitant Medications Stroke Stroke
C54924 Work responsibility level previous resume indicator

Indicator of whether the subject/participant has resumed their previous level of responsibility at work

Supplemental Return to Work Stroke Stroke
C54925 Work responsibility level previous not resume reason

Reason that the subject/participant has not resumed their previous level of responsibility at work

Supplemental Return to Work Stroke Stroke
C54926 Workload after event rate

Rate in hours per week of the subject/participant's workload subsequent to the event

Supplemental Return to Work Stroke Stroke
C54923 Workload before event rate

Rate in hours per week of the subject/participant's workload prior to the event

Supplemental Return to Work Stroke Stroke
C54921 Unruptured intracranial aneurysm treatment repair score

Score in favor of repair on the unruptured intracranial aneurysm (UIA) treatment score model

Supplemental Unruptured Intracranial Aneurysm Management Stroke Stroke
C54922 Unruptured intracranial aneurysm treatment management score

Score in favor of management on the unruptured intracranial aneurysm (UIA) treatment score model

Supplemental Unruptured Intracranial Aneurysm Management Stroke Stroke
C54920 Unruptured intracranial aneurysm rupture risk PHASES score

Score on the PHASES scale for the risk of rupture of unruptured intracranial aneurysm (UIA)

Supplemental Unruptured Intracranial Aneurysm Management Stroke Stroke
C54919 Unruptured intracranial aneurysm management noncompliance text

The free-text field related to 'Unruptured intracranial aneurysm management compliance indicator' specifying noncompliance

Exploratory Unruptured Intracranial Aneurysm Management Stroke Stroke
C54918 Unruptured intracranial aneurysm management compliance indicator

Indicator of whether the subject/participant is complying with advice for the management of his or her unruptured intracranial aneurysm (UIA)

Exploratory Unruptured Intracranial Aneurysm Management Stroke Stroke
C54916 Unruptured intracranial aneurysm observation reason

Reason for observation only of unruptured intracranial aneurysm (UIA)

Exploratory Unruptured Intracranial Aneurysm Management Stroke Stroke
C54917 Unruptured intracranial aneurysm treatment reason

Reason for treatment of unruptured intracranial aneurysm (UIA)

Exploratory Unruptured Intracranial Aneurysm Management Stroke Stroke
Displaying 501 - 525 of 1543

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.